DKCM
HZNP

Davidson Kempner Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Davidson Kempner Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,076,379
Closed -$356M – 328
2023
Q3 		$356M Sell
3,076,379
-183,812
-6% -$19.8M 4.67% 5
2023
Q2 		$335M Sell
3,260,191
-1,218,323
-27% -$129M 6.46% 1
2023
Q1 		$489M Buy
4,478,514
+1,924,861
+75% +$213M 8.14% 1
2022
Q4 		$290M Buy
+2,553,653
New +$212M 5.51% 1

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Davidson Kempner Capital Management's HZNP Position: Q4 2023 in Review

Davidson Kempner Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 3,076,379 shares — an estimated $356M sold.

Davidson Kempner Capital Management first reported a position in HZNP in Q4 2022 and held it in 4 quarters. The position peaked at $489M in Q1 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Davidson Kempner Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 3,076,379 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $356M.
  • Davidson Kempner Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022 and held it in 4 quarters.
  • Davidson Kempner Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $489M in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Davidson Kempner Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.